These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 30221089)

  • 1. Effects of resveratrol, exercises and their combination on
    Hajighasem A; Farzanegi P; Mazaheri Z; Naghizadeh M; Salehi G
    PeerJ; 2018; 6():e5522. PubMed ID: 30221089
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The ameliorating effect of withaferin A on high-fat diet-induced non-alcoholic fatty liver disease by acting as an LXR/FXR dual receptor activator.
    Shiragannavar VD; Sannappa Gowda NG; Puttahanumantharayappa LD; Karunakara SH; Bhat S; Prasad SK; Kumar DP; Santhekadur PK
    Front Pharmacol; 2023; 14():1135952. PubMed ID: 36909161
    [No Abstract]   [Full Text] [Related]  

  • 3. Effects of combined therapy with resveratrol, continuous and interval exercises on apoptosis, oxidative stress, and inflammatory biomarkers in the liver of old rats with non-alcoholic fatty liver disease.
    Hajighasem A; Farzanegi P; Mazaheri Z
    Arch Physiol Biochem; 2019 May; 125(2):142-149. PubMed ID: 29463133
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of N-Acetyl cysteine on the expression of Fxr (Nr1h4), LXRα (Nr1h3) and Sirt1 genes, oxidative stress, and apoptosis in the liver of rats exposed to different doses of cadmium.
    Azarmehr Z; Ranji N; Khazaei Koohpar Z; Habibollahi H
    Mol Biol Rep; 2021 Mar; 48(3):2533-2542. PubMed ID: 33772418
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acanthoic acid modulates lipogenesis in nonalcoholic fatty liver disease via FXR/LXRs-dependent manner.
    Han X; Cui ZY; Song J; Piao HQ; Lian LH; Hou LS; Wang G; Zheng S; Dong XX; Nan JX; Wu YL
    Chem Biol Interact; 2019 Sep; 311():108794. PubMed ID: 31421115
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effect of geniposidic acid on hepato-enteric circulation in cholestasis rats through Sirt1-FXR signaling pathway].
    Chen H; Li J; Hu L; Zhao W; Yu H; Liu HZ; Ma ST
    Zhongguo Zhong Yao Za Zhi; 2019 Feb; 44(4):787-795. PubMed ID: 30989893
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-apoptotic properties of N-Acetyl cysteine and its effects on of Liver X receptor and Sirtuin 1 expression in the liver of rats exposed to Lead.
    Harchegani AB; Rostami S; Mohsenifar Z; Dafchahi AB; Moghadam FM; Jaafarzadeh M; Saraabestan SS; Ranji N
    J Trace Elem Med Biol; 2022 Dec; 74():127070. PubMed ID: 36155419
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of nuclear receptor FXR on the regulation of liver lipid metabolism in patients with non-alcoholic fatty liver disease.
    Yang ZX; Shen W; Sun H
    Hepatol Int; 2010 Aug; 4(4):741-8. PubMed ID: 21286345
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of aerobic, resistance, and combined training on PPAR-α, SIRT1 gene expression, and insulin resistance in high-fat diet-induced NAFLD male rats.
    Nikroo H; Hosseini SRA; Fathi M; Sardar MA; Khazaei M
    Physiol Behav; 2020 Dec; 227():113149. PubMed ID: 32888948
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Duodenal Niemann-Pick C1-like 1 expression was negatively correlated with liver X receptor expression in nonalcoholic fatty liver disease.
    Ahn SB; Jun DW; Jang K; Lee BH; Shin KJ
    Korean J Intern Med; 2019 Jul; 34(4):777-784. PubMed ID: 29466845
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protective effects of farnesoid X receptor (FXR) on hepatic lipid accumulation are mediated by hepatic FXR and independent of intestinal FGF15 signal.
    Schmitt J; Kong B; Stieger B; Tschopp O; Schultze SM; Rau M; Weber A; Müllhaupt B; Guo GL; Geier A
    Liver Int; 2015 Apr; 35(4):1133-1144. PubMed ID: 25156247
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting Sirt1 in a rat model of high-fat diet-induced non-alcoholic fatty liver disease: Comparison of Gegen Qinlian decoction and resveratrol.
    Guo Y; Li JX; Mao TY; Zhao WH; Liu LJ; Wang YL
    Exp Ther Med; 2017 Nov; 14(5):4279-4287. PubMed ID: 29104641
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Resveratrol attenuates hepatic steatosis in high-fat fed mice by decreasing lipogenesis and inflammation.
    Andrade JM; Paraíso AF; de Oliveira MV; Martins AM; Neto JF; Guimarães AL; de Paula AM; Qureshi M; Santos SH
    Nutrition; 2014; 30(7-8):915-9. PubMed ID: 24985011
    [TBL] [Abstract][Full Text] [Related]  

  • 14. FXR agonist GW4064 alleviates endotoxin-induced hepatic inflammation by repressing macrophage activation.
    Yao J; Zhou CS; Ma X; Fu BQ; Tao LS; Chen M; Xu YP
    World J Gastroenterol; 2014 Oct; 20(39):14430-41. PubMed ID: 25339829
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Resveratrol Ameliorates Lipid Droplet Accumulation in Liver Through a SIRT1/ ATF6-Dependent Mechanism.
    Zhou R; Yi L; Ye X; Zeng X; Liu K; Qin Y; Zhang Q; Mi M
    Cell Physiol Biochem; 2018; 51(5):2397-2420. PubMed ID: 30537742
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Berberine ameliorates nonalcoholic fatty liver disease by decreasing the liver lipid content via reversing the abnormal expression of MTTP and LDLR.
    Chen P; Li Y; Xiao L
    Exp Ther Med; 2021 Oct; 22(4):1109. PubMed ID: 34504563
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Resveratrol attenuates steatosis in obese Zucker rats by decreasing fatty acid availability and reducing oxidative stress.
    Gómez-Zorita S; Fernández-Quintela A; Macarulla MT; Aguirre L; Hijona E; Bujanda L; Milagro F; Martínez JA; Portillo MP
    Br J Nutr; 2012 Jan; 107(2):202-10. PubMed ID: 21733326
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and safety of the farnesoid X receptor agonist obeticholic acid in patients with type 2 diabetes and nonalcoholic fatty liver disease.
    Mudaliar S; Henry RR; Sanyal AJ; Morrow L; Marschall HU; Kipnes M; Adorini L; Sciacca CI; Clopton P; Castelloe E; Dillon P; Pruzanski M; Shapiro D
    Gastroenterology; 2013 Sep; 145(3):574-82.e1. PubMed ID: 23727264
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of Calorie-Restricted Diet and Resveratrol Supplementation on Anthropometric Indices, Metabolic Parameters, and Serum Sirtuin-1 Levels in Patients With Nonalcoholic Fatty Liver Disease: A Randomized Controlled Clinical Trial.
    Asghari S; Asghari-Jafarabadi M; Somi MH; Ghavami SM; Rafraf M
    J Am Coll Nutr; 2018; 37(3):223-233. PubMed ID: 29313746
    [TBL] [Abstract][Full Text] [Related]  

  • 20. n-3 Polyunsaturated fatty acids for the management of alcoholic liver disease: A critical review.
    Wang M; Ma LJ; Yang Y; Xiao Z; Wan JB
    Crit Rev Food Sci Nutr; 2019; 59(sup1):S116-S129. PubMed ID: 30580553
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.